Getty Images' AI Uncertainty, FX Headwinds, Premium Valuation Spark Downgrade JPMorgan analyst downgrades Getty Images stock to Underweight due to high premium, AI uncertainty, growth headwinds.
Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.